SENTINEL LEVEL CLINICAL LABORATORY GUIDELINES FOR SUSPECTED AGENTS OF BIOTERRORISM AND EMERGING INFECTIOUS DISEASES Coxiella burnetii American Society for Microbiology (ASM) Revised March 2016 For latest revision, see web site below: https://www.asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C ASM Subject Matter Expert: David Welch, Ph.D. Medical Microbiology Consulting Dallas, TX
[email protected] ASM Sentinel Laboratory Protocol Working Group APHL Advisory Committee Vickie Baselski, Ph.D. Barbara Robinson-Dunn, Ph.D. Patricia Blevins, MPH University of Tennessee at Department of Clinical San Antonio Metro Health Memphis Pathology District Laboratory Memphis, TN Beaumont Health System
[email protected] [email protected] Royal Oak, MI BRobinson- Erin Bowles David Craft, Ph.D.
[email protected] Wisconsin State Laboratory of Penn State Milton S. Hershey Hygiene Medical Center Michael A. Saubolle, Ph.D.
[email protected] Hershey, PA Banner Health System
[email protected] Phoenix, AZ Christopher Chadwick, MS
[email protected] Association of Public Health Peter H. Gilligan, Ph.D. m Laboratories University of North Carolina
[email protected] Hospitals/ Susan L. Shiflett Clinical Microbiology and Michigan Department of Mary DeMartino, BS, Immunology Labs Community Health MT(ASCP)SM Chapel Hill, NC Lansing, MI State Hygienic Laboratory at the
[email protected] [email protected] University of Iowa
[email protected] Larry Gray, Ph.D. Alice Weissfeld, Ph.D. TriHealth Laboratories and Microbiology Specialists Inc. Harvey Holmes, PhD University of Cincinnati College Houston, TX Centers for Disease Control and of Medicine
[email protected] Prevention Cincinnati, OH om
[email protected] [email protected] David Welch, Ph.D.